Kuros Biosciences's total assets for Q2 2025 were CHF109.97M, an increase of 30.08% from the previous quarter. CH:KURN total liabilities were CHF33.32M for the fiscal quarter, a 29.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.